Smart inhaler trial aims to help asthma patients breathe easier
NCT ID NCT03890666
First seen Apr 03, 2026 · Last updated May 21, 2026 · Updated 7 times
Summary
This study tested whether a digital inhaler system (a smart inhaler with an app) helps people with asthma gain better control of their condition. About 333 people aged 13 and older with asthma took part. Half used the smart inhaler system, and the other half used their usual rescue inhaler. The goal was to see if the smart system leads to meaningful improvement in asthma control after 12 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Teva Investigational Site 14187
Cincinnati, Ohio, 45231, United States
-
Teva Investigational Site 14188
San Antonio, Texas, 78207, United States
-
Teva Investigational Site 14189
San Antonio, Texas, 78251, United States
-
Teva Investigational Site 14190
Greenfield, Wisconsin, 53228, United States
-
Teva Investigational Site 14191
Owensboro, Kentucky, 42301, United States
-
Teva Investigational Site 14192
San Antonio, Texas, 78229, United States
-
Teva Investigational Site 14195
Savannah, Georgia, 31406, United States
-
Teva Investigational Site 14196
Greenville, South Carolina, 29607, United States
-
Teva Investigational Site 14197
Aventura, Florida, 33180, United States
-
Teva Investigational Site 14198
Denver, Colorado, 80206, United States
-
Teva Investigational Site 14200
Providence, Rhode Island, 02906, United States
-
Teva Investigational Site 14207
Bellevue, Nebraska, 68123-4303, United States
-
Teva Investigational Site 14208
Pittsburgh, Pennsylvania, 15241, United States
-
Teva Investigational Site 14210
Philadelphia, Pennsylvania, 19140, United States
-
Teva Investigational Site 14215
Sarasota, Florida, 34239, United States
-
Teva Investigational Site 14217
Evanston, Illinois, 60201, United States
-
Teva Investigational Site 14218
Springfield, Illinois, 62704, United States
-
Teva Investigational Site 14220
New Haven, Connecticut, 06510, United States
-
Teva Investigational Site 14221
New York, New York, 10461, United States
-
Teva Investigational Site 14232
Birmingham, Alabama, 35209, United States
-
Teva Investigational Site 14233
Ann Arbor, Michigan, 48109, United States
-
Teva Investigational Site 14234
Chapel Hill, North Carolina, 27599, United States
-
Teva Investigational Site 14236
Colorado Springs, Colorado, 80907, United States
-
Teva Investigational Site 14300
Charleston, South Carolina, 29407, United States
-
Teva Investigational Site 14301
Stockton, California, 95207-6204, United States
-
Teva Investigational Site 14302
Los Angeles, California, 90025, United States
-
Teva Investigational Site 14304
Albany, Georgia, 31707, United States
-
Teva Investigational Site 14305
Louisville, Kentucky, 40215, United States
-
Teva Investigational Site 14306
Miami, Florida, 33186, United States
Conditions
Explore the condition pages connected to this study.